Jianlong Zhuang1, Chunnuan Chen2, Yuying Jiang1, Qi Luo3, Shuhong Zeng1, Chunling Lv4, Yuanbai Wang5, Wanyu Fu6. 1. Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, 362000, People's Republic of China. 2. Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, 362000, People's Republic of China. 3. Department of Public Health for Women and Children, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, 362000, People's Republic of China. 4. Zhejiang Biosan Technology Co., Ltd, Hangzhou, Zhejiang, 310000, People's Republic of China. 5. Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, 362000, People's Republic of China. wybslj@163.com. 6. Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, Fujian, 362000, People's Republic of China. 272399258@qq.com.
Abstract
BACKGROUND: An increasing number of techniques have been used for prenatal diagnosis of genetic abnormalities. Our initial objective was to explore the value of the BACs-on-Beads (BoBs) assay for the prenatal diagnosis of aneuploidies and microdeletion/microduplication syndromes in Quanzhou, Southeast China. METHODS: A total of 1409 pregnant women with high-risk factors for chromosomal abnormalities admitted to Quanzhou Women's and Children's Hospital were enrolled in this study. BoBs assays and karyotype analyses were conducted for all subjects. Subsequently, chromosome microarray analysis (CMA) or fluorescence in situ hybridization (FISH) was performed to validate the findings. RESULTS: In this study, karyotype analysis and BoBs assay failed in 4 cases, and 2 cases, respectively. A total of 1403 cases were successfully analyzed, with success rates of 99.72% (1405/1409) and 99.85% (1407/1409) for karyotype analysis and Bobs assay, respectively. BoBs assay rapidly detected chromosomal aneuploidies in line with the karyotyping data. Additionally, 23 cases of microdeletions/microduplications were detected by BoBs assay but missed by karyotyping, including 22q11.2 microdeletions/microduplications, 5p15.32p15.33 microdeletion, Xp22.31 microdeletions/microduplications, Xq27.3 microdeletion, and Yp11.2 and Yq11.22q11.222 microduplication. In comparison with karyotyping, fewer mosaicisms were identified by BoBs assay. A high detection rate of chromosomal abnormalities was observed in the high-risk group during noninvasive prenatal testing (NIPT) (41.72%) and the abnormal ultrasound group (13.43%). CONCLUSIONS: BoBs assay can be used for the rapid and efficient prenatal diagnosis of common aneuploidies and microdeletion/microduplication syndromes. Moreover, the combined use of BoBs assay and karyotyping in prenatal diagnosis may allow for a more effective detection of chromosomal abnormalities.
BACKGROUND: An increasing number of techniques have been used for prenatal diagnosis of genetic abnormalities. Our initial objective was to explore the value of the BACs-on-Beads (BoBs) assay for the prenatal diagnosis of aneuploidies and microdeletion/microduplication syndromes in Quanzhou, Southeast China. METHODS: A total of 1409 pregnant women with high-risk factors for chromosomal abnormalities admitted to Quanzhou Women's and Children's Hospital were enrolled in this study. BoBs assays and karyotype analyses were conducted for all subjects. Subsequently, chromosome microarray analysis (CMA) or fluorescence in situ hybridization (FISH) was performed to validate the findings. RESULTS: In this study, karyotype analysis and BoBs assay failed in 4 cases, and 2 cases, respectively. A total of 1403 cases were successfully analyzed, with success rates of 99.72% (1405/1409) and 99.85% (1407/1409) for karyotype analysis and Bobs assay, respectively. BoBs assay rapidly detected chromosomal aneuploidies in line with the karyotyping data. Additionally, 23 cases of microdeletions/microduplications were detected by BoBs assay but missed by karyotyping, including 22q11.2 microdeletions/microduplications, 5p15.32p15.33 microdeletion, Xp22.31 microdeletions/microduplications, Xq27.3 microdeletion, and Yp11.2 and Yq11.22q11.222 microduplication. In comparison with karyotyping, fewer mosaicisms were identified by BoBs assay. A high detection rate of chromosomal abnormalities was observed in the high-risk group during noninvasive prenatal testing (NIPT) (41.72%) and the abnormal ultrasound group (13.43%). CONCLUSIONS: BoBs assay can be used for the rapid and efficient prenatal diagnosis of common aneuploidies and microdeletion/microduplication syndromes. Moreover, the combined use of BoBs assay and karyotyping in prenatal diagnosis may allow for a more effective detection of chromosomal abnormalities.
Authors: F Vialard; G Simoni; A Aboura; S De Toffol; D Molina Gomes; L Marcato; S Serero; P Clement; P Bouhanna; E Rouleau; B Grimi; J Selva; E Gaetani; F Maggi; A Joseph; B Benzacken; F R Grati Journal: Prenat Diagn Date: 2011-03-14 Impact factor: 3.050
Authors: Francesca Romana Grati; Denise Molina Gomes; Jose Carlos Pinto B Ferreira; Celine Dupont; Viola Alesi; Laetitia Gouas; Nina Horelli-Kuitunen; Kwong Wai Choy; Sandra García-Herrero; Alberto Gonzalez de la Vega; Krzysztof Piotrowski; Rita Genesio; Gloria Queipo; Barbara Malvestiti; Bérénice Hervé; Brigitte Benzacken; Antonio Novelli; Philippe Vago; Kirsi Piippo; Tak Yeung Leung; Federico Maggi; Thibault Quibel; Anne Claude Tabet; Giuseppe Simoni; François Vialard Journal: Prenat Diagn Date: 2015-06-24 Impact factor: 3.050
Authors: Yvonne K Y Cheng; Cherry Wong; Hoi Kin Wong; Kwok On Leung; Yvonne K Kwok; Andy Suen; Chi Chui Wang; Tak Yeung Leung; Kwong Wai Choy Journal: Prenat Diagn Date: 2012-11-20 Impact factor: 3.050
Authors: J C Sitek; M A Kulseth; K B Rypdal; T Skodje; Y Sheng; L Retterstøl Journal: J Eur Acad Dermatol Venereol Date: 2018-03-09 Impact factor: 6.166